IDH1 and intrahepatic cholangiocarcinoma: This is the first clinical trial to describe the toxicity profile, safety and pharmacokinetics of the combination of metformin and chloroquine in patients with IDH1-mutated chondrosarcoma, glioma and intrahepatic cholangiocarcinoma.